CMPI.org

In the News

IHME Director hints at new COVID-19 models

04/16/2020 12:00 AM | Fox News

Clinical trial plans for vaccine, treatment accelerates

04/11/2020 12:00 AM | Fox News

Combating COVID-19: Coronavirus Antibodies test

04/09/2020 12:00 AM | CBN

CMPI's Peter Pitts talks social distancing and vaccine development process

04/08/2020 12:00 AM | KTLA 5

Now Is Not the Time to Chill Drug Research

04/07/2020 12:00 AM | Inside Sources

How the public sector is working with private firms to fight COVID-19

04/04/2020 12:00 AM | The Washington Times

Are we close to a coronavirus medical breakthrough?

03/27/2020 12:00 AM | Fox News

Coronavirus sweeping across the U.S.

03/18/2020 12:00 AM | Newsmax TV

Coronavirus: America’s drug supply needs a refill

03/05/2020 12:00 AM | NY Daily News

The coronavirus could help pharma reset its reputation in Washington

03/03/2020 12:00 AM | STAT

Keep Canadian drugs out of U.S. medicine cabinets

02/27/2020 12:00 AM | The Washington Times

Prescription for Failure: The Ills of Socialized Medicine (CPAC 2020)

02/27/2020 12:00 AM | CPAC 2020

How to eliminate surprise medical bills

02/12/2020 12:00 AM | The Washington Times

AARP's Stop Rx Greed Campaign Should Focus on AARP's Rx Greed

01/13/2020 12:00 AM | CMPI

True Cost of Socialized Medicine & the Right Way to Hold Down the Cost of Healthcare

10/16/2019 12:00 AM | CPAC Atlanta

FDA is smashing the status quo for regulatory science

10/14/2019 12:00 AM | STAT

Common Sense Healthcare Policy for Common Sense Americans (and Presidential Candidates)

08/22/2019 12:00 AM | CMPI

Three ways Congress can lower seniors’ pharmacy bills

08/08/2019 12:00 AM | The Express Times

07/02/2019 12:00 AM | Real Clear Health

HHS's ideas for rearranging Medicare would raise costs for seniors

06/18/2019 12:00 AM | The Hill

Previous
1
2
3
4
5
6
...
9
Next

RECENT NEWS

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

FDLI
09/07/2021 12:00 AM

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta... Read more

FDA Authorizes Pfizer Covid-19 Vaccine Booster for Ages 12-15

NEWSY
01/04/2022 12:00 AM

FDA Authorizes Pfizer Covid-19 Vaccine Booster for Ages 12-15

CMPI's Peter Pitts discusses FDA approval of Pfizer COVID vaccine booster for children ages 12-15... Read more

Should We Rethink The FDA Commissionership?

Health Affairs
12/22/2021 12:00 AM

Should We Rethink The FDA Commissionership?

When one considers the FDA’s mission—to independently protect consumers and advance the public health—it is not at all cl... Read more

Read all News